Dramatic improvement of inoperable angiosarcoma with combination paclitaxel and bevacizumab chemotherapy - 24/04/13
Doi : 10.1016/j.jaad.2009.09.035
Christopher K. Fuller, LCDRMC, USN a, d, John A. Charlson, MD b, Steven K. Dankle, MD c, Thomas J. Russell, MD a, ⁎ 
a Department of Dermatology, Medical College of Wisconsin, Milwaukee, Wisconsin
b Department of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin
c Department of Otolaryngology, Medical College of Wisconsin, Milwaukee, Wisconsin
d Department of Dermatology, Naval Health Clinic Great Lakes, Great Lakes, Illinois
Reprint requests: Thomas Russell, MD, Department of Dermatology, Medical College of Wisconsin, 9200 W Wisconsin Ave, Milwaukee, Wisconsin 53226.| Funding sources: None. |
|
| Conflicts of interest: None declared. |
© 2010
American Academy of Dermatology, Inc.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 63 - N° 4
P. e83-e84 - ottobre 2010 Ritorno al numero
Articolo precedente
- Dark urine and the dermatologist
- Colby Evans, Whitney A. High
- Development of monoclonal gammopathy in 12 patients receiving efalizumab treatment for chronic plaque psoriasis
- Francesca Prignano, Leonardo Pescitelli, Federica Ricceri, Angela Ermini, Torello Lotti
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?